Aug 12, 2020
IDEAYA Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update
May 15, 2020
IDEAYA Biosciences Announces AACR Abstracts for IDE196 Targeting GNAQ/11 Tumors and Preclinical MAT2A Synthetic Lethality Program
Mar 24, 2020
IDEAYA Biosciences, Inc. Reports Fourth Quarter 2019 Financial Results and Provides Business Update
Mar 18, 2020
IDEAYA and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations
May 29, 2019
Array BioPharma to Present at the Jefferies 2019 Global Healthcare Conference
May 07, 2019
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2019
Apr 30, 2019
Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2019 on May 7, 2019
Mar 05, 2019
Array BioPharma to Present at the 39th Annual Cowen Health Care Conference
Feb 21, 2019
Array BioPharma to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
Feb 05, 2019
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2019
Jan 29, 2019
Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2019 on February 5, 2019
Dec 20, 2018
Array BioPharma to Present at the 37th Annual J.P. Morgan Healthcare Conference
Nov 20, 2018
Array BioPharma to Present at the 30th Annual Piper Jaffray Healthcare Conference
Nov 06, 2018
Array BioPharma to Present at the Stifel 2018 Healthcare Conference and the Jefferies 2018 London Healthcare Conference
Oct 29, 2018
CStone announces first patient dosed in Phase I study in China for MEK inhibitor CS3006
Oct 23, 2018
Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2019 on October 30, 2018
Sep 25, 2018
Array BioPharma to Present at the 2018 Cantor Global Healthcare Conference
Sep 20, 2018
European Commission Approves BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) for Advanced BRAF-mutant Melanoma
Sep 13, 2018
Array BioPharma Announces Publication of BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) Phase 3 Overall Survival Data in The Lancet Oncology
Aug 14, 2018
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018